These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 18951988)
21. Expression profile of ADAM10 and ADAM17 in allergic rhinitis. Chueh HW; Park SK; Hur DY; Bae WY Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527 [TBL] [Abstract][Full Text] [Related]
22. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483 [TBL] [Abstract][Full Text] [Related]
23. A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Wolpert F; Tritschler I; Steinle A; Weller M; Eisele G Neuro Oncol; 2014 Mar; 16(3):382-91. PubMed ID: 24327582 [TBL] [Abstract][Full Text] [Related]
24. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435 [TBL] [Abstract][Full Text] [Related]
25. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Bozkulak EC; Weinmaster G Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010 [TBL] [Abstract][Full Text] [Related]
26. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein. Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108 [TBL] [Abstract][Full Text] [Related]
27. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Koenen RR; Pruessmeyer J; Soehnlein O; Fraemohs L; Zernecke A; Schwarz N; Reiss K; Sarabi A; Lindbom L; Hackeng TM; Weber C; Ludwig A Blood; 2009 May; 113(19):4799-809. PubMed ID: 19258599 [TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073 [TBL] [Abstract][Full Text] [Related]
29. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles. Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498 [TBL] [Abstract][Full Text] [Related]
30. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17. Zheng Y; Verhoeff TA; Perez Pardo P; Garssen J; Kraneveld AD Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374371 [TBL] [Abstract][Full Text] [Related]
31. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis. Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057 [TBL] [Abstract][Full Text] [Related]
32. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17. Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598 [TBL] [Abstract][Full Text] [Related]
33. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators. Guo S; Peng M; Zhao Q; Zhang W Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404 [TBL] [Abstract][Full Text] [Related]
34. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Eichenauer DA; Simhadri VL; von Strandmann EP; Ludwig A; Matthews V; Reiners KS; von Tresckow B; Saftig P; Rose-John S; Engert A; Hansen HP Cancer Res; 2007 Jan; 67(1):332-8. PubMed ID: 17210715 [TBL] [Abstract][Full Text] [Related]
35. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes. Ebsen H; Lettau M; Kabelitz D; Janssen O Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus. Del Turco D; Schlaudraff J; Bonin M; Deller T PLoS One; 2014; 9(1):e84962. PubMed ID: 24404197 [TBL] [Abstract][Full Text] [Related]
38. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes. Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846 [TBL] [Abstract][Full Text] [Related]
40. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]